EU Safety Gate (RAPEX) · United Kingdom in respect of Northern Ireland · 2026-09-18 · Serious risk
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
🔴 Serious hazard — Reported risk: The product contains lead (measured value: 0.005 percent by weight). Lead is harmful to human health, accumulates in the body and may affect breast-fed or unborn children. Moreover, The product contains mercury (measured value: 0.008 percent by weight). Mercury accumulates in the body and can damage the kidneys, brain and nervous system. Additionally, it may affect reproduction and the unborn child. Additionally, the product has an excessive concentration of cadmium (measured value: 0.000 9 percent by weight). Cadmium is harmful to human health because it accumulates in the body, can damage the kidneys and bones and it may cause cancer. Furthermore, the product has an excessive concentration of arsenic (measured value: 0.0008 percent by weight). Arsenic may cause cancer, may damage fertility or the unborn child, causes damage to organs through prolonged or repeated exposure. The product does not comply with the Cosmetic Products Regulation nor with the REACH Regulation.
What to do
Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →
Action taken by the authority
Type of economic operator to whom the measure were ordered
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.